Liu G, Ji W, Huang J, Liu L, Wang Y
Department of Nephrology, Qingdao Central Hospital, Qingdao, 266042, China.
Department of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
J Endocrinol Invest. 2016 Aug;39(8):865-73. doi: 10.1007/s40618-015-0428-y. Epub 2016 Feb 1.
To investigate 4-HNE expression in diabetic rat kidneys and the protective effect of probucol.
Diabetic rat models were established. Diabetic rats with successful modeling were randomly divided into the diabetic group (group D) and probucol treated group (group P). Normal rats were put into the control group (group C). Rats in group P were treated with probucol (110 mg/kg day), and rats in groups D and C were given equal volume of water instead. Serum creatinine (SCr), urea nitrogen (BUN), triglyceride (TG), total cholesterol (TC), and 24-h urinary protein were measured at the 4th, 8th, and 12th weeks. Periodic acid-schiff (PAS) staining and hematoxylin-eosin (HE) staining were used to evaluate the renal pathological changes. The immunohistochemistry and Western-blot were used to detect 4-HNE expression in renal tissue.
The SCr, BUN, TG, TC, and 24-h urinary protein in group D increased in the 4th, 8th, and 12th weeks and were higher than those in group C (P < 0.05). The SCr, BUN, TG, TC, and 24-h urinary protein in group P decreased compared to group D (P < 0.05). Pathological kidney changes in group D were more serious than those in group P. The level of 4-HNE expression in group D significantly increased at the 4th, 8th, and 12th weeks and were higher than those in group C (P < 0.05). In the kidneys treated with probucol, the level of 4-HNE significantly decreased compared to group D (P < 0.05).
Probucol can protect the diabetic kidney by decreasing 4-HNE expression and lipid peroxidation levels.
研究4-羟基壬烯醛(4-HNE)在糖尿病大鼠肾脏中的表达及普罗布考的保护作用。
建立糖尿病大鼠模型。将建模成功的糖尿病大鼠随机分为糖尿病组(D组)和普罗布考治疗组(P组)。正常大鼠作为对照组(C组)。P组大鼠给予普罗布考(110mg/kg·天),D组和C组大鼠给予等量的水。在第4、8和12周时测定血清肌酐(SCr)、尿素氮(BUN)、甘油三酯(TG)、总胆固醇(TC)和24小时尿蛋白。采用高碘酸-希夫(PAS)染色和苏木精-伊红(HE)染色评估肾脏病理变化。采用免疫组织化学和蛋白质印迹法检测肾脏组织中4-HNE的表达。
D组在第4、8和12周时SCr、BUN、TG、TC和24小时尿蛋白升高,且高于C组(P<0.05)。P组的SCr、BUN、TG、TC和24小时尿蛋白较D组降低(P<0.05)。D组肾脏病理变化比P组更严重。D组在第4、8和12周时4-HNE表达水平显著升高,且高于C组(P<0.05)。在用普罗布考治疗的肾脏中,4-HNE水平较D组显著降低(P<0.05)。
普罗布考可通过降低4-HNE表达和脂质过氧化水平来保护糖尿病肾脏。